Penumbra, Inc. (PEN)
319.15
-0.86
(-0.27%)
USD |
NYSE |
Nov 20, 16:00
319.15
0.00 (0.00%)
After-Hours: 20:00
Penumbra Total Long Term Debt (Quarterly) : 194.68M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 194.68M |
| June 30, 2026 | 198.31M |
| March 31, 2026 | 202.03M |
| December 31, 2025 | 205.86M |
| September 30, 2025 | 203.96M |
| June 30, 2025 | 207.67M |
| March 31, 2025 | 208.14M |
| December 31, 2024 | 211.17M |
| September 30, 2024 | 214.62M |
| June 30, 2024 | 217.04M |
| March 31, 2024 | 219.92M |
| December 31, 2023 | 223.14M |
| September 30, 2023 | 217.97M |
| June 30, 2023 | 220.56M |
| March 31, 2023 | 223.22M |
| December 31, 2022 | 225.74M |
| September 30, 2022 | 208.10M |
| June 30, 2022 | 210.62M |
| March 31, 2022 | 210.33M |
| December 31, 2021 | 165.28M |
| September 30, 2021 | 166.57M |
| June 30, 2021 | 122.62M |
| March 31, 2021 | 71.96M |
| December 31, 2020 | 72.58M |
| September 30, 2020 | 73.72M |
| Date | Value |
|---|---|
| June 30, 2020 | 73.14M |
| March 31, 2020 | 75.36M |
| December 31, 2019 | 78.16M |
| September 30, 2019 | 45.40M |
| June 30, 2019 | 46.15M |
| March 31, 2019 | 46.07M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Boston Scientific Corp. | 11.95B |
| Teleflex, Inc. | 1.680B |
| Integra LifeSciences Holdings Corp. | 1.988B |
| Abbott Laboratories | 31.16B |
| DexCom, Inc. | 1.372B |